Canaccord Genuity Group Reiterates “Buy” Rating for TransMedics Group (NASDAQ:TMDX)
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a report issued on Tuesday,Benzinga reports. They currently have a $104.00 price objective on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 55.04% from the stock’s previous close. A number of other equities […]
TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a report issued on Tuesday,Benzinga reports. They currently have a $104.00 price objective on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 55.04% from the stock’s previous close. A number of other equities […]
